Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI

Correlation with clinical severity

Jonathan D. Dodd, Godtfred Holmvang, Udo Hoffmann, Maros Ferencik, Suhny Abbara, Thomas J. Brady, Ricardo C. Cury

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to investigate whether MRI can quantify the severity and extent of left ventricular noncompaction and detect trabecular delayed hyperenhancement and whether doing so can show a relationship with clinical stage of disease. MATERIALS AND METHODS. In a retrospective blinded study, nine patients with left ventricular noncompaction and 10 control subjects had cardiac MRI studies evaluated for the severity and extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement on a myocardial segment basis (16-segment model). Findings were correlated with parameters of clinical stage of disease. RESULTS. Fifty-seven (39%) myocardial segments showed left ventricular noncompaction whereas 22 (17%) showed trabecular delayed hyperenhancement. Significant differences among clinical severity groups were noted in the severity and extent of left ventricular noncompaction at the mid (p < 0.05 and p < 0.005, respectively) and apical levels (p < 0.003 and p < 0.001, respectively), severity of trabecular delayed hyperenhancement at the mid (p < 0.04) and apical levels (p < 0.02), and amount of trabecular delayed hyperenhancement at the apical level (p < 0.006). The extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement correlated significantly with ejection fraction (EF) (r = -0.47, -0.53, -0.53, respectively, p < 0.05). The degree of trabecular delayed hyperenhancement was an independent predictor of EF (R2 = 0.30, p < 0.0001). Significant differences in the severity of trabecular delayed hyperenhancement were detected among patients with mild and those with moderate and severe clinical stage of disease (p < 0.0001). CONCLUSION. Cardiac MRI shows trabecular delayed hyperenhancement in left ventricular noncompaction. Evaluating the extent and severity of left ventricular noncompaction and trabecular delayed hyperenhancement may improve the ability of the clinician to predict the clinical stage of disease.

Original languageEnglish (US)
Pages (from-to)974-980
Number of pages7
JournalAmerican Journal of Roentgenology
Volume189
Issue number4
DOIs
StatePublished - Oct 2007

Fingerprint

Retrospective Studies

Keywords

  • Cardiomyopathy
  • Left ventricle abnormality
  • Left ventricular noncompaction
  • MRI
  • Trabecular delayed hyperenhancement

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI : Correlation with clinical severity. / Dodd, Jonathan D.; Holmvang, Godtfred; Hoffmann, Udo; Ferencik, Maros; Abbara, Suhny; Brady, Thomas J.; Cury, Ricardo C.

In: American Journal of Roentgenology, Vol. 189, No. 4, 10.2007, p. 974-980.

Research output: Contribution to journalArticle

Dodd, Jonathan D. ; Holmvang, Godtfred ; Hoffmann, Udo ; Ferencik, Maros ; Abbara, Suhny ; Brady, Thomas J. ; Cury, Ricardo C. / Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI : Correlation with clinical severity. In: American Journal of Roentgenology. 2007 ; Vol. 189, No. 4. pp. 974-980.
@article{ae2870b384dd4ef484be1d869d7e9158,
title = "Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: Correlation with clinical severity",
abstract = "OBJECTIVE. The purpose of this study was to investigate whether MRI can quantify the severity and extent of left ventricular noncompaction and detect trabecular delayed hyperenhancement and whether doing so can show a relationship with clinical stage of disease. MATERIALS AND METHODS. In a retrospective blinded study, nine patients with left ventricular noncompaction and 10 control subjects had cardiac MRI studies evaluated for the severity and extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement on a myocardial segment basis (16-segment model). Findings were correlated with parameters of clinical stage of disease. RESULTS. Fifty-seven (39{\%}) myocardial segments showed left ventricular noncompaction whereas 22 (17{\%}) showed trabecular delayed hyperenhancement. Significant differences among clinical severity groups were noted in the severity and extent of left ventricular noncompaction at the mid (p < 0.05 and p < 0.005, respectively) and apical levels (p < 0.003 and p < 0.001, respectively), severity of trabecular delayed hyperenhancement at the mid (p < 0.04) and apical levels (p < 0.02), and amount of trabecular delayed hyperenhancement at the apical level (p < 0.006). The extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement correlated significantly with ejection fraction (EF) (r = -0.47, -0.53, -0.53, respectively, p < 0.05). The degree of trabecular delayed hyperenhancement was an independent predictor of EF (R2 = 0.30, p < 0.0001). Significant differences in the severity of trabecular delayed hyperenhancement were detected among patients with mild and those with moderate and severe clinical stage of disease (p < 0.0001). CONCLUSION. Cardiac MRI shows trabecular delayed hyperenhancement in left ventricular noncompaction. Evaluating the extent and severity of left ventricular noncompaction and trabecular delayed hyperenhancement may improve the ability of the clinician to predict the clinical stage of disease.",
keywords = "Cardiomyopathy, Left ventricle abnormality, Left ventricular noncompaction, MRI, Trabecular delayed hyperenhancement",
author = "Dodd, {Jonathan D.} and Godtfred Holmvang and Udo Hoffmann and Maros Ferencik and Suhny Abbara and Brady, {Thomas J.} and Cury, {Ricardo C.}",
year = "2007",
month = "10",
doi = "10.2214/AJR.07.2364",
language = "English (US)",
volume = "189",
pages = "974--980",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "4",

}

TY - JOUR

T1 - Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI

T2 - Correlation with clinical severity

AU - Dodd, Jonathan D.

AU - Holmvang, Godtfred

AU - Hoffmann, Udo

AU - Ferencik, Maros

AU - Abbara, Suhny

AU - Brady, Thomas J.

AU - Cury, Ricardo C.

PY - 2007/10

Y1 - 2007/10

N2 - OBJECTIVE. The purpose of this study was to investigate whether MRI can quantify the severity and extent of left ventricular noncompaction and detect trabecular delayed hyperenhancement and whether doing so can show a relationship with clinical stage of disease. MATERIALS AND METHODS. In a retrospective blinded study, nine patients with left ventricular noncompaction and 10 control subjects had cardiac MRI studies evaluated for the severity and extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement on a myocardial segment basis (16-segment model). Findings were correlated with parameters of clinical stage of disease. RESULTS. Fifty-seven (39%) myocardial segments showed left ventricular noncompaction whereas 22 (17%) showed trabecular delayed hyperenhancement. Significant differences among clinical severity groups were noted in the severity and extent of left ventricular noncompaction at the mid (p < 0.05 and p < 0.005, respectively) and apical levels (p < 0.003 and p < 0.001, respectively), severity of trabecular delayed hyperenhancement at the mid (p < 0.04) and apical levels (p < 0.02), and amount of trabecular delayed hyperenhancement at the apical level (p < 0.006). The extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement correlated significantly with ejection fraction (EF) (r = -0.47, -0.53, -0.53, respectively, p < 0.05). The degree of trabecular delayed hyperenhancement was an independent predictor of EF (R2 = 0.30, p < 0.0001). Significant differences in the severity of trabecular delayed hyperenhancement were detected among patients with mild and those with moderate and severe clinical stage of disease (p < 0.0001). CONCLUSION. Cardiac MRI shows trabecular delayed hyperenhancement in left ventricular noncompaction. Evaluating the extent and severity of left ventricular noncompaction and trabecular delayed hyperenhancement may improve the ability of the clinician to predict the clinical stage of disease.

AB - OBJECTIVE. The purpose of this study was to investigate whether MRI can quantify the severity and extent of left ventricular noncompaction and detect trabecular delayed hyperenhancement and whether doing so can show a relationship with clinical stage of disease. MATERIALS AND METHODS. In a retrospective blinded study, nine patients with left ventricular noncompaction and 10 control subjects had cardiac MRI studies evaluated for the severity and extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement on a myocardial segment basis (16-segment model). Findings were correlated with parameters of clinical stage of disease. RESULTS. Fifty-seven (39%) myocardial segments showed left ventricular noncompaction whereas 22 (17%) showed trabecular delayed hyperenhancement. Significant differences among clinical severity groups were noted in the severity and extent of left ventricular noncompaction at the mid (p < 0.05 and p < 0.005, respectively) and apical levels (p < 0.003 and p < 0.001, respectively), severity of trabecular delayed hyperenhancement at the mid (p < 0.04) and apical levels (p < 0.02), and amount of trabecular delayed hyperenhancement at the apical level (p < 0.006). The extent of left ventricular noncompaction and the amount and degree of trabecular delayed hyperenhancement correlated significantly with ejection fraction (EF) (r = -0.47, -0.53, -0.53, respectively, p < 0.05). The degree of trabecular delayed hyperenhancement was an independent predictor of EF (R2 = 0.30, p < 0.0001). Significant differences in the severity of trabecular delayed hyperenhancement were detected among patients with mild and those with moderate and severe clinical stage of disease (p < 0.0001). CONCLUSION. Cardiac MRI shows trabecular delayed hyperenhancement in left ventricular noncompaction. Evaluating the extent and severity of left ventricular noncompaction and trabecular delayed hyperenhancement may improve the ability of the clinician to predict the clinical stage of disease.

KW - Cardiomyopathy

KW - Left ventricle abnormality

KW - Left ventricular noncompaction

KW - MRI

KW - Trabecular delayed hyperenhancement

UR - http://www.scopus.com/inward/record.url?scp=34748904610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748904610&partnerID=8YFLogxK

U2 - 10.2214/AJR.07.2364

DO - 10.2214/AJR.07.2364

M3 - Article

VL - 189

SP - 974

EP - 980

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 4

ER -